<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) - June 17, 1997
Advanced Viral Research Corp.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 33-2262-A 59-2646820
- -------------------- --------------- ------------------
(State or other juris- (Commission File (IRS Employer
diction of incorporation) Number) Identification No.)
1250 East Hallandale Beach Blvd., Suite 501
Hallandale, Florida 33009
------------------------------------------- ----------
(Address or principal executive offices) (zip code)
Registrant's telephone number, including area code: (954) 458-7636
----------------
NONE
-----------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
Item 1. Changes in Control of Registrant
- ------- --------------------------------
Not Applicable
Item 2. Acquisition or Disposition of Assets
- ------- ------------------------------------
Not Applicable
Item 3. Bankruptcy or Receivership
- ------- --------------------------
Not Applicable
Item 4. Changes in Registrant's Certifying Accountant
- ------- ---------------------------------------------
Not Applicable
Item 5. Other Events
- ------- ------------
Not Applicable
Item 6. Resignations of Registrant's Directors
- ------- --------------------------------------
On June 17, 1997, Robert C. Kolodny, M.D. and William J. Gedale
resigned from the Company's Board of Directors.
Item 7. Financial Statements and Exhibits
- ------- ---------------------------------
(a) Financial statements of businesses acquired
None
(b) Pro forma financial information
None
(c) Exhibits
None
Item 8. Change in Fiscal Year
- ------- ---------------------
Not Applicable
Item 9. Sales of Equity Securities Pursuant to Regulation S
- ------- ---------------------------------------------------
Not Applicable
List of Exhibits
- ----------------
99.1 Resignation of Robert C. Kolodny, M.D.
99.2 Resignation of William J. Gedale
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ADVANCED VIRAL RESEARCH CORP.
(Registrant)
Dated: June 17, 1997 By:/s/ Shalom Z. Hirschman, M.D.
-----------------------------
Shalom Z. Hirschman, M.D.
<PAGE> 1
BEHAVIORAL MEDICINE INSTITUTE
886 OENOKE RIDGE ROAD
NEW CANAAN, CT 06540
TEL 203-966-8060
FAX 203-966-9807
ROBERT C. KOLODNY, M.D.
MEDICAL DIRECTOR
17 June 1997
Dr. Shalom Z. Hirschman
President
Advanced Viral Research
200 Corporate Blvd. South
Yonkers, NY 10701 BY FAX
------
Dear Dr. Hirschman:
This is to formally inform you that I am resigning from my position as a
board member of Advanced Viral Research effective immediately.
I wish you the best of luck in your future work.
Sincerely,
/s/ Robert C. Kolodny
- ---------------------------------
Robert C. Kolodny, M.D.
<PAGE> 1
EVEREST CAPITAL ADVISORS, LLC
1775 BROADWAY - SUITE 1410
NEW YORK, NY 10019
TELEPHONE: 212-561-3737 FAX 212-561-4909
June 17, 1997
Mr. Shalom Hirschman
President and CEO
Advanced Viral Research
200 Corporate Blvd. South
Yonkers, New York 10701
Dear Shalom,
I hereby resign as a director of Advanced Viral Research Corporation. The best
of luck in pursuing your worthy goals.
Sincerely yours,
/s/ William J. Gedale
- -------------------------------
William J. Gedale
